Omidria maintains mydriasis, reduces postop pain

OMS302, a combination of phenylephrine and ketorolac, prevented intraoperative miosis in patients undergoing cataract surgery better than its individual components or vehicle, according to a study.The multicenter randomized clinical trial evaluated 222 cataract surgery patients randomized to receive intracameral Omidria (phenylephrine 1%/ketorolac 0.03%, Omeros), phenylephrine, ketorolac or vehicle.

Full Story →